Author:
Tully Michael,Wedepohl Stefanie,Kutifa Daniel,Weise Christoph,Licha Kai,Schirner Michael,Haag Rainer
Funder
Federal Ministry of Education and Research Bonn Office
German Research Foundation
Subject
Pharmaceutical Science,General Medicine,Biotechnology
Reference60 articles.
1. Exenatide and rare adverse events;Cure;N. Engl. J. Med.,2008
2. Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes;Kolterman;J. Clin. Endocrinol. Metab.,2003
3. Byetta package insert, Amylin Pharmaceuticals, San Diego, 2009.
4. Half-life extended biotherapeutics;Kontermann;Exp. Opin. Biol. Ther.,2016
5. An evidence-based and practical approach using Bydureon in patients with type 2 diabetes;Painter;J. Am. Board. Fam. Med.,2013
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献